Submit Deal

Submit Deal

Announced

1 Feb 2020

Completed

1 Feb 2020

Laboratoires Théa completed the acquisition of the eye care business of Similasan.

Synopsis

Laboratoires Théa, an independent ophthalmic pharmaceutical group, completed the acquisition of the eye care business of Similasan, a manufacturer of bulk organic and inorganic medicinal chemicals and pharmaceuticals. Financial terms were not disclosed.

Principals

target

Similasan (eye Care Business)

bidder

Laboratoires Thea

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (15)

Service Providers

Sort

Urs Lehmann

ManagerCEO at SIMILASAN

Roger Thomi

LawyerAssociate at Baker McKenzie

Alexander Fischer

LawyerPartner at Baker McKenzie

Alexander Blaeser

LawyerAssociate at Baker McKenzie

Boris Wenger

LawyerPartner at Baker McKenzie

Michael J. Fieweger

LawyerPartner at Baker McKenzie

Julia Schieber

LawyerSenior Associate at Baker McKenzie

Fabian Greutert

LawyerAssociate at Baker McKenzie

Susanne Vogt

ManagerCorporate Communication at SIMILASAN

Andrea Bolliger

LawyerOf Counsel at Baker McKenzie

Lukas Glanzmann

LawyerPartner at Baker McKenzie

Daniel Kalin

LawyerAssociate at Baker McKenzie

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.